Immunoregulation and Therapeutic Precision in Rheumatoid Arthritis

Bidragets beskrivning

Rheumatoid arthritis (RA) is a common debilitating autoimmune disease, which symptoms include joint pain and fatigue. Despite intensive research, RA is incurable, and its etiology is only partially understood. Novel biological drugs have improved the treatment outcome, although the disease cannot be efficiently managed in all patients. In Heal-Art, we study the disease mechanisms underlying RA. Based on our results we aim to develop novel more effective and better tolerated treatments. We focus on the so called JAK-STAT pathway, which is the key mediator of inflammation. In our projects, we utilize patient samples, cell lines and mouse models of RA. We collect clinical information together with laboratory data of RA patients and in collaboration with rheumatologists we have developed a mathematical model to predict drug-induced side-effects. Our results will enable more individualized diagnostics and treatment of RA in the future, and thus benefit both the patients and the society.
Visa mer

Startår

2021

Slutår

2023

Beviljade finansiering





Laura Elo Orcid -palvelun logo
134 374 €

Rollen i Finlands Akademis konsortium

Övriga parter i konsortiet

Partner
Aalto-universitetet (335436)
131 899 €
Partner
Tammerfors universitet (335437)
199 949 €
Leader
Helsingfors universitet (335432)
207 750 €
Partner
Åbo universitet (335435)
176 028 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprogram

Övriga uppgifter

Finansieringsbeslutets nummer

335434

Vetenskapsområden

Biokemi, cell- och molekylärbiologi

Forskningsområden

Solu- ja molekyylibiologia

Identifierade teman

musculoskeletal diseases